CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2

Abstract excerpt

This is a consensus statement from an international group, mostly of clinical endocrinologists. MEN1 and MEN2 are hereditary cancer syndromes. The commonest tumors secrete PTH or gastrin in MEN1, and calcitonin or catecholamines in MEN2. Management strategies improved after the discoveries of their genes. MEN1 has no clear syndromic variants. Tumor monitoring in MEN1 carriers includes biochemical tests yearly and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Neuroendocrine Tumor Research Advances
• Share to Pancreatic and Hepatic Oncology Research
• Share to Thyroid Cancer Diagnosis and Treatment